The initial public offer of Mankind Pharma was subscribed 9% till 4.00 pm on day 1 of the offer. Click here to subscribe the IPO.
The retail investors’ part was subscribed 8%, non-institutional investors’ (NIIs’) portion was subscribed 20%. However, there were no bids for the QIB category.
The Rs 4,300-crore IPO is completely an offer for sale (OFS), will conclude on April 27. Investors can bid for 13 shares in 1 lot and in multiples thereof.
The company has reserved about 50% of the issue size for qualified institutional buyers (QIBs), 35% for retail investors and the remaining 15% for non-institutional investors.
Mankind Pharma IPO important details
Open date | April 25 |
Close date | April 27 |
Lot size | 13 |
IPO size (Rs crore) | Rs 4,326.36 Cr |
IPO price range (Rs) | Rs 1026-1080 per share |
Minimum investment | Rs 14,040 |
Basis of allotment date | May 3 |
Refunds date | May 4 |
Credit to demat account date | May 5 |
Listing date | May 8 |
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.